Gomes-Trolin C, Gottfries C G, Regland B, Oreland L
Department of Medical Pharmacology, University of Uppsala, Sweden.
J Neural Transm (Vienna). 1996;103(7):861-72. doi: 10.1007/BF01273364.
The influence of vitamin B12 on the activity of methionine adenosyltransferase (MAT) in postmortem brains of patients with senile dementia of the Alzheimer's type (SDAT) was investigated. In samples of cortex gyrus frontalis from SDAT patients with normal and low levels of serum B12, MAT Vmax was significantly increased by 25% and 19%, respectively. MAT Vmax from a SDAT group chronically treated with B12 was similar to controls. In contrast to cortex gyrus frontalis, no significant alterations were seen in MAT activity in nucleus caudatus. This study provides evidence that SDAT is associated with significant alterations in transmethylation mechanisms in specific regions of the brain. The relationship between blood levels of B12 and the actual status of this vitamin in the brain influencing the rates of synthesis of both methionine and SAM may, however, be far more complex and cannot be directly clarified on the basis of the present human brain results.
研究了维生素B12对阿尔茨海默型老年性痴呆(SDAT)患者死后大脑中蛋氨酸腺苷转移酶(MAT)活性的影响。在血清B12水平正常和较低的SDAT患者的额回皮质样本中,MAT的Vmax分别显著增加了25%和19%。长期接受B12治疗的SDAT组的MAT Vmax与对照组相似。与额回皮质不同,尾状核中的MAT活性未见明显改变。这项研究提供了证据,表明SDAT与大脑特定区域的转甲基化机制的显著改变有关。然而,血液中B12水平与大脑中这种维生素的实际状态之间的关系,影响蛋氨酸和SAM的合成速率,可能要复杂得多,不能根据目前人脑的研究结果直接阐明。